Here are three highlights:
1. The Incision-less Anastomosis System facilitates a non-surgical procedure that treats Type 2 diabetes in obese patients.
2. Christopher C. Thompson, MD, director of developmental endoscopy at Brigham and Women’s Hospital in Boston, is the founder of GI Windows.
3. GI Windows is a West Bridgewater, Mass.-based clinical-stage medical device company that develops non-surgical procedures for Type 2 diabetes and other metabolic diseases.
More articles on GI & endoscopy:
Gastroenterologist to know: Dr. Matthew Bechtold of University of Missouri Health School of Medicine
4 GI physicians in the news — May 13, 2016
Synthetic Biologics names Dr. Isaac Bright VP: 4 points
